Related Experiment Video
Updated: May 31, 2026

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
Impact of predicted microbiota tryptophanase activity on Cryptosporidium parvum proliferation
Debora Regina Romualdo da Silva1,2, Xiaojiao Yang3, Giovanni Widmer1
1Cummings School of Veterinary Medicine at Tufts University, Department of Infectious Diseases & Global Health, North Grafton, Massachusetts, United States of America.
Abstract:
Protozoa in the genus Cryptosporidium infect intestinal epithelial cells. The profile of the fecal microbiota has been shown to impact the proliferation of Cryptosporidium parvum in a mouse model of cryptosporidiosis and a reverse effect of the parasite on the microbiota has also been described. The mechanisms underlying this interaction are unknown. The lack of effective drugs and vaccines is motivating the search for pro- or prebiotics capable of increasing resistance to parasite proliferation in the gastrointestinal tract. To understand if and how the intestinal microbiota could be harnessed for this purpose, we tested if C. parvum proliferation in the mouse responds to oral administration of Escherichia coli. This bacterium was chosen because of its reported importance in mediating colonization resistance, because it encodes tryptophanase, an enzyme which converts tryptophan into indole, and because of the availability of an ampicillin-resistant strain expressing green fluorescent protein. Excretion of GFP+ E. coli in the feces was highly variable among mice, a phenomenon which is also observed with C. parvum. A positive correlation between fecal output of probiotic E. coli and C. parvum was observed. This finding may indicate that intestinal colonization with two microorganisms as different as E. coli and C. parvum responds to the same conditions in the GI tract. Consistent with an effect of the microbiota on cryptosporidiosis, the pre-infection microbiota taxonomic profile was predictive of mouse susceptibility to C. parvum. Contrary to the reported inhibitory effect of indole on C. parvum, microbiota indole production potential was positively correlated with C. parvum fecal output. The effect of cryptosporidiosis on the microbiota was characterized by an expansion of facultative anaerobes, particularly Gammaproteobacteria. This study is a first attempt to assess the proliferation in the mouse of a defined probiotic and quantify its effect on C. parvum development.
Insights
Investigating the gut microbiota
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Cryptosporidium parvum infects intestinal cells, and its proliferation is influenced by gut microbiota.
- Mechanisms of this interaction and potential probiotic interventions remain largely unknown.
- Lack of effective treatments necessitates exploring strategies like probiotics for cryptosporidiosis.
Purpose of the Study:
- To investigate if oral administration of Escherichia coli affects Cryptosporidium parvum proliferation in mice.
- To explore the role of the gut microbiota and indole production in cryptosporidiosis.
Main Methods:
- Oral administration of ampicillin-resistant, GFP-expressing E. coli to mice.
- Quantification of fecal E. coli and C. parvum output.
- Analysis of pre-infection microbiota composition and indole production potential.
Main Results:
- A positive correlation was observed between fecal E. coli and C. parvum output.
- Pre-infection microbiota profiles predicted susceptibility to C. parvum.
- Indole production potential correlated positively with C. parvum output, contrary to expectations.
- Cryptosporidiosis led to an expansion of facultative anaerobes, notably Gammaproteobacteria.
Conclusions:
- Gut microbiota composition influences C. parvum susceptibility.
- E. coli administration did not inhibit, but rather correlated with, C. parvum proliferation in this model.
- This study provides initial insights into the complex interplay between a defined probiotic, the gut microbiota, and C. parvum infection.

